Medicine & Life Sciences
Sarcoma
100%
Drug Therapy
33%
Neoplasms
33%
Osteosarcoma
33%
pazopanib
32%
Survival
30%
Gastrointestinal Stromal Tumors
29%
Progression-Free Survival
24%
Radiotherapy
24%
Ewing's Sarcoma
23%
Therapeutics
22%
gemcitabine
21%
regorafenib
18%
Leiomyosarcoma
17%
Doxorubicin
16%
TH 302
15%
Imatinib Mesylate
14%
Aggressive Fibromatosis
14%
Liposarcoma
11%
Recurrence
11%
Hemangiosarcoma
10%
Placebos
10%
mocetinostat
10%
Confidence Intervals
10%
Stomatitis
9%
Myxoid Liposarcoma
9%
Safety
9%
Squamous Cell Carcinoma of Head and Neck
9%
Bevacizumab
9%
Squamous Cell Carcinoma
9%
Small Cell Lung Carcinoma
8%
Synovial Sarcoma
8%
Cisplatin
8%
Radiation
8%
atezolizumab
8%
Neurofibrosarcoma
8%
Survival Rate
8%
pembrolizumab
8%
temsirolimus
8%
Response Evaluation Criteria in Solid Tumors
7%
eIF-2 Kinase
7%
Spine
7%
Bone and Bones
7%
Somatomedin Receptors
7%
Neoplasm Metastasis
7%
Chondrosarcoma
6%
Glutamine
6%
Irinotecan
6%
Prodrugs
6%
Docetaxel
6%